Viread and Aldactone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Viread and Aldactone. Common interactions include sepsis among females and anxiety among males.

The phase IV clinical study analyzes what interactions people who take Viread and Aldactone have. It is created by eHealthMe based on reports of 79 people who take Viread and Aldactone from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Dec, 03, 2022

79 people who take Viread and Aldactone together, and have interactions are studied.


What is Viread?

Viread has active ingredients of tenofovir disoproxil fumarate. It is often used in hepatitis b. eHealthMe is studying from 46,326 Viread users for its effectiveness, alternative drugs and more.

What is Aldactone?

Aldactone has active ingredients of spironolactone. It is often used in acne. eHealthMe is studying from 43,449 Aldactone users for its effectiveness, alternative drugs and more.

Number of Viread and Aldactone reports submitted per year:

Viread and Aldactone drug interactions.

Common Viread and Aldactone drug interactions by gender *:

female:

  1. Sepsis
  2. Blood glucose decreased
  3. Blood in stool
  4. Bradycardia
  5. Cardio-respiratory arrest
  6. Diarrhoea
  7. Emotional distress
  8. Hypotension
  9. Lactic acidosis
  10. Mitral valve incompetence

male:

  1. Anxiety
  2. Vomiting
  3. White blood cell count decreased
  4. Chronic kidney disease
  5. Alanine aminotransferase increased
  6. Dizziness
  7. Gamma-glutamyltransferase increased
  8. Liver disorder
  9. Depression
  10. Aspartate aminotransferase increased

Common Viread and Aldactone drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Asterixis
  2. Hyperammonaemia
  3. Dyspnoea
  4. Splenomegaly
  5. Ammonia increased
  6. Asthenia
  7. Back pain
  8. Blood lactic acid increased
  9. Guillain-barre syndrome
  10. Headache

40-49:

  1. Renal impairment
  2. Pain
  3. Anhedonia
  4. Anxiety
  5. Emotional distress
  6. Pancreatitis
  7. Sepsis
  8. Blood glucose decreased
  9. Blood in stool
  10. Bradycardia

50-59:

  1. Multiple fractures
  2. Nausea
  3. Photosensitivity reaction
  4. Pleural effusion
  5. Proteinuria
  6. Renal tubular necrosis
  7. Road traffic accident
  8. Social avoidant behaviour
  9. Squamous cell carcinoma of skin
  10. Tachypnoea

60+:

  1. Vomiting
  2. Febrile neutropenia
  3. Prothrombin time ratio decreased
  4. Urinary incontinence
  5. Bone density decreased
  6. Emotional distress
  7. Foot fracture
  8. Hip fracture
  9. Multiple fractures
  10. Osteopenia

Common conditions people have *:

  1. Hiv Infection: 31 people, 39.24%
  2. Hepatocellular Carcinoma (liver cancer): 12 people, 15.19%
  3. High Blood Pressure: 11 people, 13.92%
  4. Depression: 8 people, 10.13%
  5. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 6 people, 7.59%
  6. High Blood Cholesterol: 6 people, 7.59%
  7. Ascites (accumulation of fluid in the abdominal cavity): 6 people, 7.59%
  8. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 5 people, 6.33%
  9. Pain: 5 people, 6.33%
  10. Diarrhea: 5 people, 6.33%

* Approximation only. Some reports may have incomplete information.

Do you take Viread and Aldactone?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Common Viread and Aldactone interactions:

Browse all drug interactions of Viread and Aldactone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Viread interactions:

Browse all interactions between Viread and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Aldactone interactions:

Browse all interactions between Aldactone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on tenofovir disoproxil fumarate and spironolactone (the active ingredients of Viread and Aldactone, respectively), and Viread and Aldactone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Viread and Aldactone.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: